The potential for normal tissue dose reduction with neoadjuvant hormonal therapy in conformal treatment planning for stage C prostate cancer

Farley E. Yang, George T.Y. Chen, Paul Ray, Florin Vaida, Parvathi Chiru, Russell J. Hamilton, Danny Spelbring, Milagros Abellera, Srinivasan Vijayakumar

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Fingerprint

Dive into the research topics of 'The potential for normal tissue dose reduction with neoadjuvant hormonal therapy in conformal treatment planning for stage C prostate cancer'. Together they form a unique fingerprint.